Hamrick Investment Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Hamrick Investment Counsel's AMGN Position: Q2 2026 in Review
Hamrick Investment Counsel reduced its Amgen (AMGN) stake by 15% in Q2 2026, selling an estimated $511K and leaving 8,334 shares worth $3.02M. The position accounts for 2% of the portfolio, ranked #11.
Hamrick Investment Counsel first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.46M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Hamrick Investment Counsel held 8,334 shares of Amgen worth $3.02M as of Q2 2026.
- Hamrick Investment Counsel sold 1,492 Amgen shares in Q2 2026, an estimated $511K.
- Amgen made up 2% of Hamrick Investment Counsel's portfolio in Q2 2026, its #11 holding.
- Hamrick Investment Counsel first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
- Hamrick Investment Counsel's Amgen position peaked at $3.46M in Q1 2026.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Hamrick Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.